Syngene International, an integrated research, development and manufacturing services company, announced that it has extended its ongoing research collaboration with Bristol Myers Squibb. The collaboration has been extended through the end of 2030 and will expand the breadth of drug discovery research conducted, including chemistry, biology, drug metabolism and pharmacokinetics, as well as translational medicine research and pharmaceutical development, including chemical process development and analytical sciences, in the coming years.
- Read more about Syngene International extendslong termresearch collaboration with BristolMyers Squibb until 2030
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/syngene-international-extendslong-termresearch-collaboration-with-bristolmyers-squibb-until-2030
No comments:
Post a Comment